Integrated Safety and Efficacy Analysis of FMX103 1.5% Topical Minocycline Foam for the Treatment of Moderate-to-Severe Papulopustular Rosacea: Results From Two Phase 3 Studies. J of Skin 2020, 4 (5), s55. https://doi.org/10.25251/skin.4.supp.54.